Atlas Trials

A Non-inferiority Study on Dose Reduction of Adalimumab in Psoriasis Patients Who Are Overtreated

Clinical trial NCT05683054 · COMPLETED

Trial details

NCT number
NCT05683054
Sponsor
University Hospital, Ghent
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Psoriasis
Start date
2020-08-11
Primary completion
2022-03-22
Enrollment
19

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.